Wei Lin
2021
In 2021, Wei Lin earned a total compensation of $3.7M as Chief Medical Officer at Erasca.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $221,450 |
| Option Awards | $2,703,937 |
| Salary | $426,265 |
| Other | $153,523 |
| Total | $3,705,175 |
Lin received $2.7M in option awards, accounting for 73% of the total pay in 2021.
Lin also received $200K in bonus, $221.5K in non-equity incentive plan, $426.3K in salary and $153.5K in other compensation.
Rankings
In 2021, Wei Lin's compensation ranked 3,604th out of 12,415 executives tracked by ExecPay. In other words, Lin earned more than 71.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,604 out of 12,415 | 71st |
Division Manufacturing | 1,470 out of 5,508 | 73rd |
Major group Chemicals And Allied Products | 597 out of 2,378 | 75th |
Industry group Drugs | 531 out of 2,099 | 75th |
Industry Pharmaceutical Preparations | 372 out of 1,549 | 76th |
Source: SEC filing on April 28, 2022.
Lin's colleagues
We found two more compensation records of executives who worked with Wei Lin at Erasca in 2021.